Get started
AMGEN 22/52AMGEN 22/52AMGEN 22/52

AMGEN 22/52

No trades
See on Supercharts
Overview
Analysis News

AMGD chart


Full chart

Key terms


Outstanding amount
‪894.54 M‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
4.20% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
6.56%
Maturity date
Feb 22, 2052
Term to maturity
27 years

About AMGEN 22/52


Issuer
Amgen, Inc.
Sector
Health Technology
Industry
Biotechnology
Home page
amgen.com
Issue date
Feb 22, 2022
FIGI
BBG015H3LLL9
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGD analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

AMGD news